At Press Time
"Gift of Sight" Tradition Lives On
Holiday Season Cataract Surgeries for the Needy.
By René Luthe, Senior Associate Editor
■ In an interesting coincidence, the philanthropic impulses of two ophthalmic surgeons led them to participate in unrelated programs for free cataract surgeries for the needy that happen to have the same name: "The Gift of Sight."
Robert P. Lehmann, M.D., of Nacogdoches, Texas, just celebrated the 16th year of his Gift of Sight program, which he founded in east Texas. Scheduled annually on the Monday before Thanksgiving, Dr. Lehmann created the program to fill what he saw as an urgent need. "There were so many who presented with vision loss from cataracts but no ability to pay for the necessary surgery," recalls Dr. Lehmann. "They weren't old enough to be on Medicare and they had no insurance or access to other programs. I decided I was going to do one eye of each of those patients at no charge. I think we did five or six that year. And then it grew until we did almost 30 eyes this year."
Originally scheduled during the Thanksgiving-Christmas season, the practice eventually settled on the Monday before Thanksgiving. "It seemed like the most obvious time of year to share something truly special, the gift of sight, with those truly in need," explains Dr. Lehmann.
The majority of candidates are referred by comanaging area optometrists and physicians. Throughout the year, they send the practice information on needy candidates. Beginning in September, the practice asks candidates to come in for a complete cataract evaluation. The needed cataract surgery is performed in one eye on the Gift of Sight day, and many patients come back to have the other cataract removed the next year.
Dr. Lehmann has been able to restore sight to patients who had been living under very trying conditions. "One patient was blind in one eye and had developed a mature cataract in her sighted eye. She lived alone and had resorted to ‘walking’ around her house on her knees to reduce the injuries from falling," Dr. Lehmann says. "She was well into her 70s, but had never been eligible for Medicare."
Dr. Robert Lehmann with a cataract patient on his "Gift of Sight" day.
While many of the patients are elderly, congenital and trauma-induced cataracts mean that young people need the surgery as well. Dr. Lehmann operated on one patient who was only 13 years old. Representatives from ophthalmic companies such as Alcon donate IOLs and other necessary supplies. "Without doubt it is the most gratifying day of the year," Dr. Lehmann says.
At Nature Coast EyeCare Institute in Perry, Fla., the practice continued its Gift of Sight initiative in memory of its founder, Joel K. Shugar, M.D., who died in a skydiving accident last May. Their program is also scheduled just before Thanksgiving. This was their ninth year of participation, with James Roberts, M.D., and Richard Palmer, M.D., performing the surgeries in order to keep the tradition going. Dr. Shugar had performed an average of 30 free cataract surgeries, and some years as many as 50. This year, they did only 12 as they adjusted to a practice without a full-time surgeon to replace Dr. Shugar. Practice Administrator Mary Ann Prevatt says Nature Coast intends to perform greater numbers again as soon as possible.
"We've probably done about 370 surgeries in the 9 years we've had the Gift of Sight program," notes Prevatt.
Like Dr. Lehmann's practice, Nature Coast sees patients with cataracts so severe that they have been compelled to stop working and driving. "This was the first time that Dr. Roberts has ever done anything like that [Gift of Sight]," Prevatt says. "And he told me, ‘These are some of the worst cataract cases I've ever done in 22 years of surgery.’"
The practice advertises in local newspapers to find candidates.
Alcon donates IOLs to Nature Coast as well; eye drops come from both Alcon and ISTA Pharmaceutical. Even the local doughnut shop participates, Prevatt reports, donating snacks for surgery day.
Nature Coast's goal is to persuade ophthalmic surgeons all over the United States to participate in the Gift of Sight. "Dr. Shugar's brother has set up a foundation called the Shugar Magic Foundation to help get this going," Prevatt says.
GIVING BACK: Committed to Compassion:
Dr. Palmon's Humanitarian Efforts Started Early.
By Jerry Helzner, Senior Editor
■ After compiling a highly impressive academic record at Georgetown University, where he was a Phi Beta Kappa and graduated magna cum laude, Rick Palmon moved on to the Tulane University School of Medicine, where he was trying to decide on an area of medical practice that would best suit him.
There, a classmate, who would later become his wife, urged him to consider ophthalmology, which she said could be an interesting and rewarding career for both of them.
"She soon lost interest in ophthalmology and became a radiologist," recalls Dr. Palmon. "But I fell in love with it. Ophthalmology met two of my primary goals: building long-term relationships with patients and an opportunity to develop my surgical skills."
As a resident at Wills Eye Hospital in Philadelphia, Dr. Palmon was able to spend 3 weeks on a humanitarian mission to rural areas of the Philippines.
"I was born and raised in the United States, but my family originally came from the Philippines," he says. "It was a good opportunity to see the country and also to provide eye care to people who have very little and a great need for this kind of care."
After a fellowship at the University of Minnesota in cornea and refractive surgery, Dr. Palmon established himself in practice in Florida, where he is now a partner in Southwest Florida Eye Care, based in Fort Myers. Dr. Palmon then found time to participate in two ORBIS missions — one to Mongolia and another to China — and a church-sponsored mission to the Dominican Republic.
In October of 2008, he went on his second trip to Haiti, part of an ongoing effort sponsored by the Northwest Haiti Christian Mission. The trip was particularly timely because Haiti was ravaged by four hurricanes in 2008 and times are harder than ever in that impoverished country with the loss of most of the important rice crop.
PHOTO COURTESY OF RICK PALMON, M.D.
Dr. Palmon (right) performed sight-giving corneal transplant surgery on the two young Haitian girls who joined him and a colleague for this photo.
"Two Kansas City ophthalmologists, Drs. Bill White and Andy Moyes, deserve most of the credit for this mission," says Dr. Palmon. "Dr. White has been doing this for 7 years and Dr. Moyes for 4 years. This was a real team effort. We had five U.S. doctors plus support staff in Haiti for a week and saw about 800 patients. We did cataract surgeries, laser treatments for severe glaucoma and also treated corneal disease and pterygium."
One of the highlights of the trip for Dr. Palmon was performing corneal transplants that brought sight to two young girls blinded by congenital corneal disease. A third child, a boy, also received a new cornea in a procedure performed by Dr. Moyes.
"These were the first corneal transplants performed in Haiti in more than 25 years," says Dr. Palmon. "We got the corneas from the Tampa Lions Eye Bank, used ice to keep them at the proper temperature, and performed the surgeries as soon as possible after we reached the clinic in St. Louis du Nord."
Care has since been turned over to two local ophthalmologists, Drs. Cedric Marcelus and Bridget Hudicort.
"We are in close touch with them," says Dr. Palmon. "The first 3 to 6 months are crucial. Children are more likely to reject corneal transplants than adults but so far they are doing well."
Though Dr. Palmon has already been on a number of missions, he still feels he can do more.
"I have a partner now so I think I can start doing two trips a year," he says. "I am committed to the Haiti mission and I would like to do one other trip each year, possibly to Africa or India. I can think of nothing more rewarding than to go into an area where the need is great and restore people's sight."
IN THE NEWS |
---|
■ Positive trial data for Durezol. Sirion Therapeutics reports that in a 90-patient clinical study for anterior uveitis, Durezol (difluprednate ophthalmic emulsion) 0.05% dosed q.i.d. was effective in both reducing cell grade and ocular discomfort. At day 14, patients on Durezol achieved a mean cell grade reduction of 2.1 and at day 7, Durezol patients averaged a 71% pain reduction from baseline using a visual analog scale. Durezol was recently approved by the FDA for reducing inflammation and pain associated with ocular surgery. ■ New treatment for corneal ulcers. RegeneRx Biopharmaceuticals said that its ophthalmic drug candidate, RGN-259, was used to treat four neurotrophic keratitis patients with non-healing eye ulcers caused primarily by the herpes zoster virus under a "Compassionate Use Investigational New Drug" application. RGN-259 is a sterile eye drop formulation of TB4 being developed by RegeneRx for use in treating ophthalmic wounds and related disorders. Steven Dunn, M.D., a corneal specialist and the sponsor/principal investigator of the IND, utilized RGN-259 to treat the corneal ulcers that had not healed for at least 6 weeks and in some cases several months, despite all standard treatments. In all four patients, the eye ulcers either completely healed or demonstrated significant improvement by treatment day 28, the maximum treatment period allowed under the clinical protocol. The patients were followed for an additional 30 days post-treatment. The results showed that completely healed ulcers remained healed and those that had demonstrated significant improvement continued to improve after treatment by RGN-259 was stopped. RGN-259 was well-tolerated and there were no drug-related adverse events. ■ Dr. Chang premium IOL module. Eyemaginations has released a comprehensive premium IOL patient education program that was developed in collaboration with David F. Chang, M.D. The software is designed to help ophthalmologists and their staff provide patients with a balanced and comprehensive overview of IOL options available with cataract surgery. "David Chang is one of the most respected authorities on cataract surgery and refractive IOLs and we are honored to have our software shaped and designed with his tone and style," said Jeffrey Peres, president and CEO of Eyemaginations. "In addition to his clinical research on new IOLs, Dr. Chang has written extensively about patient selection, education and expectations." ■ B&L drug moves toward approval. The FDA Dermatologic and Ophthalmic Drugs Advisory Committee has voted unanimously to recommend approval of Bausch & Lomb's besifloxacin ophthalmic suspension, 0.6%, for the treatment of bacterial conjunctivitis. The company has developed this broad-spectrum, anti-infective drop specifically for ophthalmic use. The drug still requires final FDA approval. ■ Once-a-day Xibrom trial. ISTA Pharmaceutical reported mixed results from two phase 3 studies of once-a-day Xibrom QD as a treatment for inflammation and pain following cataract surgery. While the integrated results of the two studies did show statistically significant effectiveness for reducing both inflammation and pain, when taken individually one of the studies did not meet the endpoints. ISTA has agreed to begin a confirmatory phase 3 study this year. ■ Joseph H. Calhoun, M.D., dies at 72. Joseph H. Calhoun, a highly respected pediatric ophthalmologist who was affiliated with Wills Eye Hospital for many years, has died at age 72. Dr. Calhoun was a former president of the American Association for Pediatric Ophthalmology and was co-author of the book "A Child's Eyes," which was voted the best medical book of 1999. Dr. Calhoun also had a long association with Project Orbis, participating on a number of international medical missions. ■ New generic for glaucoma. Prasco Laboratories said it has begun shipping generic forms of dorzolamide hydrochloride/timolol maleate and dorzolamide hydrochloride ophthalmic Solutions. The former is comparable to Merck's Cosopt and the latter to Merck's Trusopt glaucoma medications. "We are extremely pleased to be able to offer these products (including the patented Ocumeter Plus dispensing container) under our agreement with Merck," said Prasco CEO E. Thomas Arington. Go to www.prasco.com for more information. ■ New OMIC chairman. The Ophthalmic Mutual Insurance Company (OMIC) said that Richard L. Abbott, M.D., has succeeded Joe R. McFarlane Jr., M.D., J.D., as chairman of OMIC's board of directors effective January 1, 2009. The appointment of a new chairman is in keeping with OMIC's bylaws. ■ Ellex has new CEO. Simon Luscombe has been named CEO of Ellex Medical Lasers, an Australia-based maker of ophthalmic lasers and ultrasound diagnostic systems. Luscombe previously served as general manager of Ellex Australia. He has been given a mandate to restructure the company in a difficult economic environment. Luscombe replaces Kevin McGuinness who in turn replaced Peter Falzon in June. ■ B&L names VP. Bausch & Lomb has named Susan A. Roberts as a corporate vice president. She is the company's chief compliance officer, having been named to this post in 2006, and heads the global pharmacovigilance and safety surveillance groups. OM |